122 related articles for article (PubMed ID: 32648818)
21. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
22. The use of proton therapy in the treatment of gastrointestinal cancers: liver.
Dionisi F; Ben-Josef E
Cancer J; 2014; 20(6):371-7. PubMed ID: 25415681
[TBL] [Abstract][Full Text] [Related]
23. Radiation Necrosis and White Matter Lesions in Pediatric Patients With Brain Tumors Treated With Pencil Beam Scanning Proton Therapy.
Bojaxhiu B; Ahlhelm F; Walser M; Placidi L; Kliebsch U; Mikroutsikos L; Morach P; Bolsi A; Lomax T; Pica A; Weber DC
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):987-996. PubMed ID: 29485079
[TBL] [Abstract][Full Text] [Related]
24. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
Mercado CE; Hartsell WF; Simone CB; Tsai HK; Vargas CE; Zhu HJ; Henderson RH; Zeng J; Larson GL; Hoppe BS
Acta Oncol; 2019 Jul; 58(7):1036-1040. PubMed ID: 30784340
[No Abstract] [Full Text] [Related]
25. Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters.
Jung J; Yoon SM; Kim SY; Cho B; Park JH; Kim SS; Song SY; Lee SW; Ahn SD; Choi EK; Kim JH
Radiat Oncol; 2013 Oct; 8():249. PubMed ID: 24160910
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
27. Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
Velec M; Haddad CR; Craig T; Wang L; Lindsay P; Brierley J; Brade A; Ringash J; Wong R; Kim J; Dawson LA
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):939-946. PubMed ID: 28333016
[TBL] [Abstract][Full Text] [Related]
28. Radiation treatment with volumetric modulated arc therapy of hepatocellular carcinoma patients. Early clinical outcome and toxicity profile from a retrospective analysis of 138 patients.
Wang PM; Hsu WC; Chung NN; Chang FL; Fogliata A; Cozzi L
Radiat Oncol; 2012 Dec; 7():207. PubMed ID: 23216929
[TBL] [Abstract][Full Text] [Related]
29. Individualized Adaptive Stereotactic Body Radiotherapy for Liver Tumors in Patients at High Risk for Liver Damage: A Phase 2 Clinical Trial.
Feng M; Suresh K; Schipper MJ; Bazzi L; Ben-Josef E; Matuszak MM; Parikh ND; Welling TH; Normolle D; Ten Haken RK; Lawrence TS
JAMA Oncol; 2018 Jan; 4(1):40-47. PubMed ID: 28796864
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Fukuda K; Okumura T; Abei M; Fukumitsu N; Ishige K; Mizumoto M; Hasegawa N; Numajiri H; Ohnishi K; Ishikawa H; Tsuboi K; Sakurai H; Hyodo I
Cancer Sci; 2017 Mar; 108(3):497-503. PubMed ID: 28012214
[TBL] [Abstract][Full Text] [Related]
31. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
[TBL] [Abstract][Full Text] [Related]
32. Clinical results of proton therapy reirradiation for recurrent nasopharyngeal carcinoma.
Dionisi F; Croci S; Giacomelli I; Cianchetti M; Caldara A; Bertolin M; Vanoni V; Pertile R; Widesott L; Farace P; Schwarz M; Amichetti M
Acta Oncol; 2019 Sep; 58(9):1238-1245. PubMed ID: 31155998
[No Abstract] [Full Text] [Related]
33. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
34. Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy.
Lasley FD; Mannina EM; Johnson CS; Perkins SM; Althouse S; Maluccio M; Kwo P; Cárdenes H
Pract Radiat Oncol; 2015; 5(5):e443-e449. PubMed ID: 25899219
[TBL] [Abstract][Full Text] [Related]
35. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
36. Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer.
Toesca DAS; Osmundson EC; von Eyben R; Shaffer JL; Koong AC; Chang DT
Pract Radiat Oncol; 2017; 7(3):173-182. PubMed ID: 28343896
[TBL] [Abstract][Full Text] [Related]
37. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
38. What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy.
Toramatsu C; Katoh N; Shimizu S; Nihongi H; Matsuura T; Takao S; Miyamoto N; Suzuki R; Sutherland K; Kinoshita R; Onimaru R; Ishikawa M; Umegaki K; Shirato H
Radiat Oncol; 2013 Mar; 8():48. PubMed ID: 23497543
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
Yoo GS; Yu JI; Cho S; Jung SH; Han Y; Park S; Oh Y; Lee B; Park HC; Lim DH; Choi MS; Won H
Radiother Oncol; 2020 May; 146():187-193. PubMed ID: 32179362
[TBL] [Abstract][Full Text] [Related]
40. Differential Association Between Circulating Lymphocyte Populations With Outcome After Radiation Therapy in Subtypes of Liver Cancer.
Grassberger C; Hong TS; Hato T; Yeap BY; Wo JY; Tracy M; Bortfeld T; Wolfgang JA; Eyler CE; Goyal L; Clark JW; Crane CH; Koay EJ; Cobbold M; DeLaney TF; Jain RK; Zhu AX; Duda DG
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1222-1225. PubMed ID: 29859792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
